Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aminophylline for Regadenoson Side Effects in Severe CKD
NCT01336140Phase 4Completed
- Sponsor
- Rush University Medical Center
- Start
- Jun 2011
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aminophylline, sponsored by Rush University Medical Center. Started Jun 2011; status: completed.
02
Drugs
aminophylline
Beyond the preview
Go deeper on NCT01336140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01336140.